Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB13 member RAS oncogene family pseudogene (ENSG00000237493) is classified as a pseudogene in the human genome. It is related in sequence to the RAB13 gene, which encodes a member of the Rab family of small GTPases involved in membrane trafficking. However, the pseudogene does not encode a functional protein and has no recognized biological function or role as a therapeutic target. It may exist as a non-coding genomic element, typically arising from gene duplication or retrotransposition, but does not participate in canonical signaling pathways or disease processes ascribed to the functional RAB13 gene[3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB13 member RAS oncogene family pseudogene.